{
  "trial_id": "NCT03457961",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Subject aged 12 years or above",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Subject has a diagnosis of epilepsy with simple partial seizure and/or complex partial seizures",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Subjects who have a baseline seizure rate of more than 2 per month in the eight week period preceding the start of AMPA / NMDA receptor antagonist",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "No seizure free period longer than 21 days during the eight week period before AMPA receptor antagonist was started",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Patients who already had neuropsychiatric inventory completed twice during the treatment period spanning at least 16 weeks.",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Subjects with idiopathic generalised epilepsy (for example, juvenile myoclonic epilepsy and absence epilepsy)",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Patients who only suffer from isolated auras",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Baseline creatinine clearance of less than 50ml/min",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Severe hepatic impairment with ALT three times the upper limits of normal",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Significant psychiatric conditions before the start of AMPA / NMDA receptor antagonist",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Progressive neurodegenerative conditions",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Active history of malignancy",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "History of severe haematological conditions or serious blood dyscrasias",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "Patient has a history of epilepsy, CHF, and depression. He has had seizures in the past but was recently tapered off Dilantin and has been seizure-free for some time.",
  "_meta": {
    "topic_id": "9",
    "trial_id": "NCT03457961",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}